CIK 0001557746 · Non-accelerated filer<br>Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460571712
- Phone
- 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- 4 Shares withheld for taxes Chief Financial Officer gave up 286 shares (to pay taxes)
- 4 Shares withheld for taxes INTERIM PRESIDENT AND CEO gave up 2,722 shares (to pay taxes)
- 4 Option exercise INTERIM PRESIDENT AND CEO acquired 43,548 shares (option exercise)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Shares withheld for taxes INTERIM PRESIDENT AND CEO gave up 2,722 shares (to pay taxes)
- 4 Open-market buy 10% owner bought 373,569 shares at an average $1.27 ($472,757)
- 4 Open-market buy 10% owner bought 273,730 shares at an average $1.31 ($359,010)
- 4 Open-market buy 10% owner bought 154,722 shares at an average $1.30 ($201,808)
- 8-K Event Material agreement · Regulation FD disclosure
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market buy 10% owner bought 352,397 shares at an average $1.15 ($405,894)
- 4 Shares withheld for taxes INTERIM PRESIDENT AND CEO gave up 2,722 shares (to pay taxes)
- 4 Open-market buy 10% owner bought 1,543,434 shares at an average $1.13 ($1,742,075)
- 4 Open-market buy 10% owner bought 545,000 shares at an average $1.15 ($628,206)
- 4 Open-market buy 10% owner bought 1,611,200 shares at an average $1.11 ($1,781,897)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 8 of 44 · 872 filings